Alcon has generally positive cash flows and an excellent current ratio of 2.77. Additionally, the company's financial ...

Alcon’s ALC Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products.

Investors in Alcon Inc. ALC need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $70 Put had some of the highest implied volatility ...

Alcon Stock Rises Following the FDA Approval of TRYPTYR FDA approves ALC's TRYPTYR, a new dry eye treatment with rapid tear production. The approval is supported by strong Phase 3 trial results.

It features advanced automation, smart manufacturing systems, and Industry 4.0 capabilities. Alcon, a global eye care company ...

Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 million. Novartis ...

Eye care-device giant Alcon officially opened its expanded state-of-the art manufacturing and logistics facility in Tuas Biomedical Park on Friday (June 27) morning. This brings Alcon's investments in ...

Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control. In a ...

There are a few actors who walk into a room and everybody can feel that strong presence. We have several such names but we ...

Alcon Inc. (NYSE: ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced ...